Why the study?
How do the HADS and BDI-II perform in detecting major depressive disorder in adults with congenital heart disease compared to a structured clinical interview?
How do the HADS and BDI-II perform in detecting major depressive disorder in adults with congenital heart disease compared to a structured clinical interview?
Established cut-off points for HADS and BDI-II may be too high to identify mild major depressive disorder requiring therapy in adults with congenital heart disease.
May indicate standard cut-offs miss mild MDD in ACHD; leaves open population-specific validation.
All scales were excellent for detecting moderate to severe major depressive disorder. Classification of mild major depressive disorder, representing 50% of cases, was limited. Therapy necessitating loss of quality of life is already present in major depressive disorder with mild symptoms. Established cut-off points may still be too high to identify patients with major depressive disorder requiring therapy. External validation is needed to confirm our data.
No takes yet. Share an insight, caveat, or question.
Westhoff‐Bleck et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: